Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Halldin

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
European Journal of Pain (London, England)|June 12, 2024
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double-blind, placebo-controlled, crossover studyM Segerdahl, M Rother, M M Halldin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1984
A comparison between the metabolism of delta 1-tetrahydrocannabinol by perfused lung and liver of rat and guinea-pigM M Halldin, H Isaac, M Widman, et al.
Arzneimittel-Forschung|January 1, 1982
Urinary metabolites of delta 1-tetrahydrocannabinol in manM M Halldin, S Carlsson, S L Kanter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2000
Metabolism of sameridine to monocarboxylated products by hepatocytes isolated from the male ratA K Sohlenius-Sternbeck, H V Chelpin, A Orzechowski, et al.
Cancer Research|January 15, 1987
Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic neviM M Halldin, W S Cook, T Kawashima, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuanaE Johansson, M M Halldin, S Agurell, et al.
Journal of Pharmaceutical Sciences|July 20, 2016
Assessment of Free Drug Concentration in Cyclodextrin Formulations Is Essential to Determine Drug Potency in Functional In Vitro AssaysErik Sjögren, Sara Andersson, Anna K Sundgren-Andersson, et al.
Pharmacology & Toxicology|August 1, 1997
Toxicity of bupivacaine and ropivacaine in relation to free plasma concentrations in pregnant rats: a comparative studyB R Danielsson, M K Danielson, E L Böö, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1982
Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human liversM M Halldin, M Widman, C V Bahr, et al.
European Journal of Pain (London, England)|July 18, 2019
The effect of intradermal microdosing of a transient receptor potential cation channel subfamily V member 1 antagonist on heat evoked pain and thermal thresholds in normal and ultraviolet-C exposed skin in healthy volunteersErik Sjögren, Lars Ståhle, Hans Quiding, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Pain (London, England)|June 12, 2024
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double-blind, placebo-controlled, crossover studyM Segerdahl, M Rother, M M Halldin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1984
A comparison between the metabolism of delta 1-tetrahydrocannabinol by perfused lung and liver of rat and guinea-pigM M Halldin, H Isaac, M Widman, et al.
Arzneimittel-Forschung|January 1, 1982
Urinary metabolites of delta 1-tetrahydrocannabinol in manM M Halldin, S Carlsson, S L Kanter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2000
Metabolism of sameridine to monocarboxylated products by hepatocytes isolated from the male ratA K Sohlenius-Sternbeck, H V Chelpin, A Orzechowski, et al.
Cancer Research|January 15, 1987
Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic neviM M Halldin, W S Cook, T Kawashima, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuanaE Johansson, M M Halldin, S Agurell, et al.
Journal of Pharmaceutical Sciences|July 20, 2016
Assessment of Free Drug Concentration in Cyclodextrin Formulations Is Essential to Determine Drug Potency in Functional In Vitro AssaysErik Sjögren, Sara Andersson, Anna K Sundgren-Andersson, et al.
Pharmacology & Toxicology|August 1, 1997
Toxicity of bupivacaine and ropivacaine in relation to free plasma concentrations in pregnant rats: a comparative studyB R Danielsson, M K Danielson, E L Böö, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1982
Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human liversM M Halldin, M Widman, C V Bahr, et al.
European Journal of Pain (London, England)|July 18, 2019
The effect of intradermal microdosing of a transient receptor potential cation channel subfamily V member 1 antagonist on heat evoked pain and thermal thresholds in normal and ultraviolet-C exposed skin in healthy volunteersErik Sjögren, Lars Ståhle, Hans Quiding, et al.
Pageof 5